Advertisement
Screener

Benitec Biopharma Inc. (BNTC) ROA

Benitec Biopharma Inc. (BNTC) ROA

  • 2026-03-31: ROA -22.21%.
  • 2025-12-31: ROA -23.13%.
  • 2025-09-30: ROA -43.55%.
  • 2025-06-30: ROA -38.07%.

Complete source-backed roa history.

Available history
2019-06-30 to 2026-03-31
Data captured

Historical ROA

DateROA
2026-03-31-22.21%
2025-12-31-23.13%
2025-09-30-43.55%
2025-06-30-38.07%
2025-03-31-32.16%
2024-12-31-29.86%
2024-09-30-30.33%
2024-06-30-41.66%
2024-03-31-144.62%
2023-12-31-102.14%
2023-09-30-75.49%
2023-06-30-438.22%
2023-03-31-242.92%
2022-12-31-158.30%
2022-09-30-100.78%
2022-06-30-304.84%
2022-03-31-170.35%
2021-12-31-126.86%
2021-09-30-90.88%
2021-06-30-64.93%
2021-03-31-95.43%
2020-12-31-70.96%
2020-09-30-110.42%
2020-06-30-71.41%

Annual ROA

DateROA
2025-06-30-38.07%
2024-06-30-41.66%
2023-06-30-438.22%
2022-06-30-304.84%
2021-06-30-64.93%
2020-06-30-71.41%
2019-06-3013.56%

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Vogenx, Inc. (VOGX)United States$0.355B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58